跳至主要内容
临床试验/NL-OMON45948
NL-OMON45948招募中不适用

Biomarkers in ALlergic diseases and allergen Immunotherapy - BALI

Franciscus Ziekenhuis0 个研究点目标入组 160 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Positive Skin Prick Test (SPT) response of >= 8 mm wheal diameter and/or serum allergen-specific IgE levels higher than 0.70 kU/L to grass pollen, tree pollen and/or house dust mite (HDM) extract.
  • 2. Minimum of 18 years of age and a confirmed clinical diagnosis of allergic rhinitis.
  • 3. Clinical indication for AIT.
  • 4. Signed and dated informed consent (IC) form by a legally competent participant.

排除标准

  • 1. History of chronic autoimmune disease (aside from asthma, atopic dermatitis or allergic rhinitis) which may interfere with results.
  • 2. Use of an antihistamines or decongestant therapy 7 days prior to screening visit.
  • 3. Prior exposure to any monoclonal antibody treatment within the past 12 months.
  • 4. Contraindication to sublingual or subcutaneous AIT.
  • 5. Current immunosuppressive treatment.
  • 6. Current pregnancy or breastfeeding, active pregnancy wish.
  • 7. Previous immunotherapy with grass pollen, tree pollen or house dust mite extract.

研究者

发起方
Franciscus Ziekenhuis

相似试验

Biomarkers in ALlergic diseases and allergen... | 临床试验